ArticleTranslational breast cancer research : a journal focusing on translational research in breast cancer2022

Endocrine therapy leads the first- and second-line treatment options for hormone receptor-positive advanced breast cancer-comments on the Monarch plus study.

Xiaojia WangPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.